CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea · Delayed Price · Currency is KRW 1,783.00
+78.00 (4.57%)
At close: Jul 31, 2026
CU Medical Systems Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,583 | 33,289 | 40,673 | 41,050 | 59,540 | 51,576 | |
Market Cap Growth | -41.25% | -18.15% | -0.92% | -31.05% | 15.44% | -22.53% |
Enterprise Value | 55,544 | 40,670 | 65,838 | 56,832 | 70,311 | 58,869 |
Last Close Price | 1783.00 | 2750.00 | 3360.00 | 4265.00 | 6525.00 | 5725.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.82 | 40.64 | - | - | 6.32 | - |
PS Ratio | 0.39 | 0.69 | 1.00 | 0.98 | 1.27 | 1.46 |
PB Ratio | 0.29 | 0.56 | 0.69 | 0.76 | 1.00 | 1.05 |
P/TBV Ratio | 0.47 | 0.56 | 0.70 | 0.78 | 1.07 | 1.13 |
P/FCF Ratio | 1.75 | 3.86 | - | 21.69 | - | - |
P/OCF Ratio | 1.62 | 3.44 | 2.89 | 4.96 | 19.08 | 105.17 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.02 | 0.84 | 1.62 | 1.36 | 1.50 | 1.66 |
EV/EBITDA Ratio | 3.50 | 2.83 | 6.58 | 8.12 | 5.44 | 13.63 |
EV/EBIT Ratio | 4.46 | 3.67 | 8.95 | 11.23 | 6.23 | 24.78 |
EV/FCF Ratio | 4.51 | 4.71 | - | 30.03 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.64 | 0.56 | 0.63 | 0.44 | 0.33 | 0.30 |
Debt / EBITDA Ratio | 2.96 | 2.32 | 3.73 | 3.39 | 1.53 | 3.45 |
Debt / FCF Ratio | 3.81 | 3.87 | - | 12.52 | - | - |
Net Debt / Equity Ratio | 0.30 | 0.13 | 0.26 | 0.26 | 0.22 | 0.06 |
Net Debt / EBITDA Ratio | 1.41 | 0.56 | 1.51 | 1.98 | 0.98 | 0.71 |
Net Debt / FCF Ratio | 1.81 | 0.93 | -2.53 | 7.31 | -1.50 | -0.65 |
Asset Turnover | 0.46 | 0.48 | 0.43 | 0.48 | 0.58 | 0.46 |
Inventory Turnover | 2.71 | 3.60 | 2.65 | 2.13 | 2.60 | 2.03 |
Quick Ratio | 1.28 | 4.05 | 3.10 | 0.83 | 1.59 | 2.48 |
Current Ratio | 1.95 | 4.84 | 3.61 | 1.21 | 2.69 | 2.99 |
Return on Equity (ROE) | 4.45% | 1.38% | -5.53% | -14.34% | 17.57% | -29.80% |
Return on Assets (ROA) | 6.56% | 6.81% | 4.86% | 3.63% | 8.75% | 1.92% |
Return on Invested Capital (ROIC) | 12.23% | 8.46% | 10.32% | 7.23% | 16.56% | 3.91% |
Return on Capital Employed (ROCE) | 12.00% | 12.30% | 8.00% | 8.70% | 14.50% | 4.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 14.75% | 2.46% | -7.88% | -19.98% | 15.83% | -27.11% |
FCF Yield | 57.02% | 25.92% | -14.71% | 4.61% | -14.22% | -9.11% |
Buyback Yield / Dilution | -18.24% | -18.99% | -6.39% | -5.90% | -33.07% | -52.90% |